{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:11:35Z","timestamp":1790817095680,"version":"4.1.0"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2017,3,1]]},"DOI":"10.1001\/jamaoncol.2016.3904","type":"journal-article","created":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T12:31:45Z","timestamp":1478781105000},"page":"313","source":"Crossref","is-referenced-by-count":139,"title":["Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer"],"prefix":"10.1001","volume":"3","author":[{"given":"Michelle E.","family":"Melisko","sequence":"first","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindy E.","family":"Goldman","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Hwang","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"De Luca","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Fang","sequence":"additional","affiliation":[{"name":"Samuel Merritt University, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Esserman","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy J.","family":"Chien","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Park","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope S.","family":"Rugo","sequence":"additional","affiliation":[{"name":"Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9324","key":"coi160060r1","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/S0140-6736(02)09088-8","article-title":"Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial.","volume":"359","author":"Baum","year":"2002","journal-title":"Lancet"},{"issue":"8","key":"coi160060r2","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1056\/NEJMoa0810818","article-title":"Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.","volume":"361","author":"Mouridsen","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"coi160060r3","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.breast.2005.08.012","article-title":"Acceptance of adjuvant therapy and quality of life issues.","volume":"14","author":"Fallowfield","year":"2005","journal-title":"Breast"},{"issue":"21","key":"coi160060r4","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1200\/JCO.2004.08.029","article-title":"Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial.","volume":"22","author":"Fallowfield","year":"2004","journal-title":"J Clin Oncol"},{"issue":"4","key":"coi160060r6","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/annonc\/mdj127","article-title":"Caution: Vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors.","volume":"17","author":"Kendall","year":"2006","journal-title":"Ann Oncol"},{"issue":"4","key":"coi160060r7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1080\/ejc.8.4.217.224","article-title":"Low-dose intravaginal estradiol delivery using a Silastic vaginal ring for estrogen replacement therapy in postmenopausal women: a review.","volume":"8","author":"Sarkar","year":"2003","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3","key":"coi160060r8","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1200\/JOP.2011.000352","article-title":"Effects of vaginal estrogens on serum estradiol levels in postmenopausal breast cancer survivors and women at risk of breast cancer taking an aromatase inhibitor or a selective estrogen receptor modulator.","volume":"8","author":"Wills","year":"2012","journal-title":"J Oncol Pract"},{"issue":"4","key":"coi160060r9","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1634\/theoncologist.2010-0435","article-title":"Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I\/II study.","volume":"16","author":"Witherby","year":"2011","journal-title":"Oncologist"},{"issue":"8","key":"coi160060r10","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.1016\/j.clon.2012.06.009","article-title":"Are Estring\u00ae and Vagifem\u00ae equally effective and safe for the treatment of urogenital atrophy in breast cancer patients on aromatase inhibitor therapy?","volume":"24","author":"Simmons","year":"2012","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"8","key":"coi160060r11","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.steroids.2007.05.003","article-title":"Superiority of gas chromatography\/tandem mass spectrometry assay (GC\/MS\/MS) for estradiol for monitoring of aromatase inhibitor therapy.","volume":"72","author":"Santen","year":"2007","journal-title":"Steroids"},{"issue":"1","key":"coi160060r12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/2193-1801-2-5","article-title":"Deficiencies in immunoassay methods used to monitor serum Estradiol levels during aromatase inhibitor treatment in postmenopausal breast cancer patients.","volume":"2","author":"Jaque","year":"2013","journal-title":"Springerplus"},{"issue":"2","key":"coi160060r13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1200\/JCO.1998.16.2.501","article-title":"Life after breast cancer: understanding women\u2019s health-related quality of life and sexual functioning.","volume":"16","author":"Ganz","year":"1998","journal-title":"J Clin Oncol"},{"issue":"1","key":"coi160060r14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/13697130500087016","article-title":"Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.","volume":"8","author":"Weisberg","year":"2005","journal-title":"Climacteric"},{"issue":"2","key":"coi160060r15","first-page":"346","article-title":"Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy.","volume":"101","author":"Parsons","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"2","key":"coi160060r17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.steroids.2009.11.004","article-title":"Validation of a total testosterone assay using high-turbulence liquid chromatography tandem mass spectrometry: total and free testosterone reference ranges.","volume":"75","author":"Salameh","year":"2010","journal-title":"Steroids"},{"issue":"4","key":"coi160060r18","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/13697130701364644","article-title":"A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder.","volume":"10","author":"El-Hage","year":"2007","journal-title":"Climacteric"},{"issue":"15","key":"coi160060r19","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/jnci\/djm062","article-title":"Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.","volume":"99","author":"Tamimi","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"coi160060r20","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1158\/1055-9965.EPI-07-0761","article-title":"Reproductive steroid hormones and recurrence-free survival in women with a history of breast cancer.","volume":"17","author":"Rock","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"coi160060r21","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3109\/13697137.2011.642427","article-title":"Higher than expected estradiol levels in aromatase inhibitor-treated, postmenopausal breast cancer patients.","volume":"15","author":"Kunovac Kallak","year":"2012","journal-title":"Climacteric"},{"key":"coi160060r22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/1472-6882-14-484","article-title":"The effects of Cordyceps sinensis phytoestrogen on estrogen deficiency-induced osteoporosis in ovariectomized rats.","volume":"14","author":"Zhang","year":"2014","journal-title":"BMC Complement Altern Med"},{"issue":"8","key":"coi160060r23","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1016\/j.fct.2012.05.017","article-title":"Estrogenic\/antiestrogenic activities of a Epimedium koreanum extract and its major components: in vitro and in vivo studies.","volume":"50","author":"Kang","year":"2012","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"coi160060r24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1002\/(ISSN)1552-499X","article-title":"Testosterone and estradiol concentrations in serum, velvet skin, and growing antler bone of male white-tailed deer.","volume":"303","author":"Bubenik","year":"2005","journal-title":"J Exp Zool A Comp Exp Biol"},{"issue":"6","key":"coi160060r25","first-page":"1684","article-title":"Mass spectral analysis of PC-SPES confirms the presence of diethylstilbestrol.","volume":"9","author":"Guns","year":"2002","journal-title":"Can J Urol"},{"issue":"26","key":"coi160060r26","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1200\/JCO.2009.23.1225","article-title":"Breast cancer patients unknowingly dosing themselves with estrogen by using topical moisturizers.","volume":"27","author":"Olson","year":"2009","journal-title":"J Clin Oncol"},{"issue":"14","key":"coi160060r27","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1200\/JCO.2015.61.2259","article-title":"Twelve-month estrogen levels in premenopausal women with hormone receptor-positive breast cancer receiving adjuvant triptorelin plus exemestane or tamoxifen in the Suppression of Ovarian Function Trial (SOFT): the SOFT-EST substudy.","volume":"34","author":"Bellet","year":"2016","journal-title":"J Clin Oncol"},{"issue":"8","key":"coi160060r28","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1200\/JCO.1999.17.8.2371","article-title":"Predictors of sexual health in women after a breast cancer diagnosis.","volume":"17","author":"Ganz","year":"1999","journal-title":"J Clin Oncol"},{"issue":"7","key":"coi160060r29","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S1470-2045(15)00049-2","article-title":"Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.","volume":"16","author":"Bernhard","year":"2015","journal-title":"Lancet Oncol"},{"issue":"9","key":"coi160060r31","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1097\/GME.0b013e3182a122c2","article-title":"Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society.","volume":"20","year":"2013","journal-title":"Menopause"},{"key":"coi160060r5","volume-title":"Sexual Dysfunction in Women On Adjuvant Endocrine Therapy After Breast Cancer","author":"Baumgart","year":"2012"},{"key":"coi160060r16","author":"Goldman","year":"2009"},{"key":"coi160060r30","unstructured":"American College of Obstetrics and Gynecologists. Committee Opinion: The Use of Vaginal Estogen in Women with a History of Estrogen Dependent Breast Cancer. https:\/\/www.acog.org\/-\/media\/Committee-Opinions\/Committee-on-Gynecologic-Practice\/co659.pdf?dmc=1&ts=20160706T1805161170. Accessed October 10, 2016."}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2580714\/jamaoncology_melisko_2016_oi_160060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T11:02:18Z","timestamp":1595502138000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2580714"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2017,3,1]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2016.3904","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3,1]]}}}